Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Shares in Galderma jump on market debut

(Sharecast News) - Shares in Switzerland's Galderma jumped on Friday, as trading got underway in the dermatology specialist. The firm, which owns sensitive skin brand Cetaphil, among others, had announced a price range of between 49 to 53 Swiss francs (£43 to £47).

Trading opened on the SIX Swiss Exchange at SFr61, however, and continued to rise, hitting a high of SFr62.68 by mid-morning, valuing the business at SFr14.9bn.

Last year, Galderma - one of the world's largest dermatology companies - saw sales jump nearly 9%, excluding currency fluctuations, to a record $4.1bn. Core operating profits rose 21% to $942m.

Its specialist products range from acne treatments to wrinkle fillers.

Originally a joint venture between Nestle and L'Oréal, a consortium led by Swedish private equity firm EQT acquired the Zug-based business in 2019 in a $10bn deal.

EQT has sold down a proportion of its stake as part of the initial public offering, although it intends to remain a "significant" investor.

Share this article

Related Sharecast Articles

Agronomics investee Solar Foods raises EUR 8m
(Sharecast News) - Cellular agriculture investor Agronomics announced on Friday that its portfolio company Solar Foods had raised an additional €8m through Finnish investment organiser Springvest.
Berenberg hikes target price on Greggs
(Sharecast News) - Analysts at Berenberg raised their target price on bakery chain Greggs from 3,550.0p to 3,990.0p on Friday as it noted that customer appeal had broadened as its market share was expanding.
Thousands of UK firms fighting for survival - Begbies Traynor
(Sharecast News) - More than half a million UK business are fighting for survival, according to an industry research published on Friday, weighed down by the weak economy.
Thruvision FY24 adjusted underlying losses widen
(Sharecast News) - Security technology business Thruvision said on Friday that adjusted underlying losses had widened in FY24 as revenues fell.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.